
- November digital edition 2020
- Volume 12
- Issue 11
Quiz Answers: Treatments for presbyopia coming soon
1. What is the prevalence of presbyopia in the U.S.?
a. 5,000,000
b. 10,500,000
c. 50,000,000
d. 110,000,000
2. Miotics have few side effects.
a. True
b. False
3. Which of these devices uses pinhole optics (PHO)?
a. Revision Raindrop
b. Karama Inlay
c. FOV Tears
d. Allergan Presbysol
e. B and D
4. Which of these is not a pharmaco-refractive product?
a. Oraisis CSF-1
b. Presbyopia Therapies PRX-100
c. Allergan AGN
d. Eyenovia Micro-dose
e. All are pharmaco-refractive
5. What is the most common ingredient in current pharmaceutical drops for presbyopia being tested?
a. Dexamethasone
b. Pilocarpine
c. Bromfenac
d. Tropicamide
e. None of the above
6. Which of these is a device?
a. Oraisis CSF-1
b. Presbyopia Therapies PRX-100
c. Allergan AGN
d. Eyenovia Micro-dose
e. FOV Tears
7. Which is an active ingredient in PRX-100?
a. Pilocarpine
b. Tropicamide
c. Oxymetazoline
d. Polyethylene glycol
e. Diclofenac
Articles in this issue
almost 5 years ago
Quiz: Treatments for presbyopia coming soonalmost 5 years ago
When to lease and when to own office spacealmost 5 years ago
Vision rehabilitation of patients with strokealmost 5 years ago
Treatments for presbyopia coming soonalmost 5 years ago
How diabetes affects COVID-19almost 5 years ago
Novel uses of technology for systemic diseasealmost 5 years ago
Know the pros and cons of outsourcing billingalmost 5 years ago
5 communication strategies for dry eye patientsalmost 5 years ago
Association found between laminar thinning and poor cognitive functionNewsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
 
 

















































.png)


